Skip to main content
. 2020 Sep 18;8(2):e001185. doi: 10.1136/jitc-2020-001185

Figure 2.

Figure 2

Kaplan-Meier analysis of 25 patients who underwent autologous Vγ9Vδ2 T-cell therapy. (A) PFS and (B) OS. Subgroup analysis by EGFR mutational status in adenocarcinoma patients for (C) PFS and (D) OS. EGFRm (+) n=7, EGFRm (-) n=9. OS, overall survival; PFS, progression-free survival.